Experience of Using Remdesivir in Patients with Novel Coronavirus Infection
Timely, effective, and safe antiviral therapy in COVID-19 patients reduces complications, disability and mortality rates. The greatest concern with remdesivir is the risk of drug-induced liver injury, including in patients whose liver function is compromised by COVID-19.The aim of the study was to i...
Saved in:
Main Authors: | V. I. Petrov (Author), A. Yu. Ryazanova (Author), N. S. Privaltseva (Author), D. A. Nekrasov (Author) |
---|---|
Format: | Book |
Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
POLYPHARMACY IN MANAGMENT OF IN-PATIENTS WITH NOVEL CORONAVIRUS DISEASE (COVID-19)
by: V. I. Petrov, et al.
Published: (2022) -
Safety of Therapy with Tocilizumab and Other Interleukin Inhibitors
by: V. I. Petrov, et al.
Published: (2022) -
The use of convalescent plasma therapy and remdesivir in the successful management of a critically ill obstetric patient with novel coronavirus 2019 infection: A case report
by: Jonathon Anderson, et al.
Published: (2020) -
Features of the novel coronavirus infection in cancer patients
by: A. D. Makatsariya, et al.
Published: (2022) -
Current and future use of remdesivir in patients with COVID-19
by: V. M. Tsvetov, et al.
Published: (2020)